Showing results (1-10 of 199) with videos related to
Sort By:
Pageof 20
Expert Review of Anticancer Therapy|November 18, 2010
Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanomaKarl S Peggs, Sergio A QuezadaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2018
Lost in Translation: Deciphering the Mechanism of Action of Anti-human CTLA-4Sergio A Quezada, Karl S PeggsExpert Review of Anticancer Therapy|November 27, 2012
PD-1 blockade: promoting endogenous anti-tumor immunityKarl S Peggs, Sergio A QuezadaImmunological Reviews|September 2, 2008
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapyKarl S Peggs, Sergio A Quezada, James P AllisonCold Spring Harbor Perspectives in Medicine|June 21, 2017
The "Achilles' Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic StrategiesKroopa Joshi, Benjamin M Chain, Karl S Peggs, et al.Current Opinion in Immunology|February 9, 2006
Principles and use of anti-CTLA4 antibody in human cancer immunotherapyKarl S Peggs, Sergio A Quezada, Alan J Korman, et al.The Journal of Clinical Investigation|June 17, 2006
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsSergio A Quezada, Karl S Peggs, Michael A Curran, et al.Immunological Reviews|April 15, 2011
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradicationSergio A Quezada, Karl S Peggs, Tyler R Simpson, et al.Molecular Oncology|November 19, 2015
Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapyAnna Śledzińska, Laurie Menger, Katharina Bergerhoff, et al.Current Opinion in Pharmacology|May 14, 2013
Tumour heterogeneity and immune-modulationMariam Jamal-Hanjani, Eirini Thanopoulou, Karl S Peggs, et al.Pageof 20